CS Cancer Solutions - Structured Oncology Intelligence

Kansas Cancer Research Ecosystem | Precision Oncology & Genomics

Kansas Research Ecosystem

Kansas Cancer Research — Precision Oncology & Genomics

Understanding oncology research within Kansas's precision oncology and translational research ecosystem, including The University of Kansas Cancer Center

Purpose & Educational Context

This page provides an educational overview of oncology research in Kansas, with emphasis on the state's precision oncology and translational research ecosystem and The University of Kansas Cancer Center.

This page does not provide medical advice, treatment recommendations, care navigation, or referral services.

KU Cancer Center
NCI-Designated Center
Precision Oncology
Research Focus
Research Focus
Genomics
Active
Trial Expansion

Population & Regional Context

Kansas's oncology research ecosystem emphasizes precision oncology, genomics-informed care, and expansion of clinical trial participation across regional and rural communities.

NCI-Designated Cancer Center

Kansas's comprehensive cancer research infrastructure

The University of Kansas Cancer Center

NCI-Designated Cancer Center

The University of Kansas Cancer Center is Kansas's NCI-designated cancer center and serves as a central hub for genomics-guided precision oncology, clinical trial participation expansion, and translational cancer research.

Research Focus

  • •NCI-designated cancer center
  • •Genomics-guided precision oncology research
  • •Clinical trial participation expansion
  • •Translational cancer research

Research Contribution

KU Cancer Center supports Kansas's oncology research ecosystem through precision oncology research and expanded clinical trial access.

Stay Informed About Kansas Cancer Research

Get updates on Kansas-based oncology research and clinical trials.

We respect your privacy. No medical information required.

Explore More Research Resources

Access research context across U.S. states and globally

Latest Research Ecosystem Developments

Kansas — Kansas is significantly expanding its oncology research infrastructure through the construction of a state-of-the-art, $329 million cancer complex designed to integrate advanced cellular therapy manufacturing with clinical care.

Updated October 10, 2026

Topping Out of New $329 Million Cancer Research Facility

In August 2026, The University of Kansas Cancer Center celebrated the structural completion of its new cancer research and clinical building, which is designed to house laboratories, clinical spaces, and a Good Manufacturing Practice (GMP) cellular therapy laboratory under one roof.

The University of Kansas Cancer Center

$36 Million in Federal Funding Secured for Research Capacity

U.S. Senator Jerry Moran secured $36 million in federal funding in early 2026 to bolster the research capabilities of the new cancer center facility, supporting the development of innovative clinical trials and therapies.

The University of Kansas Cancer Center

Expansion of Specialized Cancer Care to Rural Kansas

In August 2026, The University of Kansas Cancer Center launched a collaboration with Citizens Medical Center in Western Kansas to provide specialized cancer care, utilizing telehealth and on-site nurse navigators to improve access for rural patients.

Hays Post

Strategic Focus on Local Cellular Therapy Manufacturing

The new cancer center complex, which broke ground in May 2025, is specifically designed to increase local manufacturing capacity for cellular therapies, aiming to expedite patient access to treatments like CAR T-cell therapy.

The University of Kansas Cancer Center

This section is refreshed on a recurring schedule. Entries are AI-assisted research signals organized from public oncology sources and should be verified against the original sources. Information is educational and does not constitute medical advice.

Huippu Prodigy Platforms

© 2026 Huippu Prodigy Platforms, LLC.

CS Cancer Solutions is operated by Huippu Prodigy Platforms, LLC.

Public-Source Oncology Research • Educational and Research Use

Structured Oncology Research Intelligence